Sima Porten

Dr. Sima Porten is a specialist in genitourinary cancers and a faculty member in the Department of Urology at the University of California San Francisco (UCSF) School of Medicine. She is part of the urologic oncology team at the UCSF Helen Diller Family Comprehensive Cancer Center, where she focuses on the diagnosis and treatment of bladder, kidney, and high-risk prostate cancers.

Her research is centered on the biological and genetic mechanisms of urothelial carcinoma, aiming to develop personalized diagnostic tools and therapies. She has published extensively on topics including urine biomarkers, molecular imaging, health disparities, and treatment outcomes in bladder cancer. Her work integrates clinical practice, translational research, and health services to improve patient care.

Dr. Porten’s recent publications reveal a strong focus on non-invasive diagnostics, molecular profiling, equity in cancer care, and innovative clinical trial design. Her research spans immunology, genetics, imaging, and patient-reported outcomes, reflecting a multidisciplinary approach to advancing bladder cancer management.

• Howard Hughes Medical Institute Research Scholar, NIH (2003)
• Alpha Omega Alpha Honor Society (2006)
• Julius R. Krevans Award for Clinical Excellence (2012)
• John Quale Travel Fellowship (2015)
• William R. Smart Distinguished Teaching Award (2017)
• Best Reviewer Award, Journal of Urology (2017)
• New Investigator Scholarship-Leadership Award, ALLIANCE Foundation (2019)
• Muriel Steele Society Honor (UCSF)

Dr. Porten has been involved in major multi-institutional research collaborations and clinical trials, including SWOG S1605 and ECOG-ACRIN EA8212, contributing to national efforts in standardizing care and evaluating novel therapies. She has received grant support through awards such as the Faculty Learning and Development Fund and the ALLIANCE Foundation. While no direct mention of advising students is made, her leadership in research and teaching suggests a mentorship role within the department. She is actively engaged in professional societies including the American Urological Association and the Society of Urologic Oncology.

Dr. Porten is affiliated with the UCSF Department of Urology and the Helen Diller Family Comprehensive Cancer Center, where she contributes to a multidisciplinary team advancing research and clinical care in urologic oncology.